|
| |
neopharm co usa Pages on BioPortfolio:
BioPortfolio - NeoPharm
NeoPharm is a pharmaceutical Company engaged in the research and development of ... Research and Development, NeoPharm Inc., Waukegan, Illinois 60085, USA. ...
http://www.bioportfolio.com/biocorporate/7437-NeoPharm.html...
|
BioPortfolio.com - BioWeb TAXOTERE DOCETAXEL genentechidec ...
... prostate, skin, stomach, other) SS1( dsFv)- PE38 NeoPharm esophageal cancer, ... USA Voicemail and Fax: (+1) 415 680 2472. All rights reserved. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...
|
BioPortfolio - Uridine
NeoPharm is a pharmaceutical Company engaged in the research and development of drugs for ... USA Voicemail and Fax: (+1) 415 680 2472. All rights reserved. ...
http://www.bioportfolio.com/indepth/Uridine.html...
|
BioPortfolio's NASDAQ Top Biotech Companies News Feed
NEOPHARM INCORPORATED · NEOSE TECHNOLOGIES INC · NEUROBIOLOGICAL TECHNOLOGIES ... USA Voicemail and Fax: (+1) 415 680 2472. All rights reserved. ...
http://www.bioportfolio.co.uk/news/nasdaq_top_bio150_1.shtml...
|
NASDAQ Biotechnology Companies - nabi - rhone-poulenc
Click on company name for: quotes, profiles, charts and opinions. ... USA Voicemail and Fax: (+1) 415 680 2472. All rights reserved. ...
http://www.bioportfolio.com/nasdaq/nasdaq_nabi_rhone.htm...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
BioCorporate - 27000 company profiles with description, contact, location map, ... USA Voicemail and Fax: (+1) 415 680 2472. All rights reserved. ...
http://www.bioportfolio.com/...
|
BioPortfolio - Bioportfolio's Biovideo
See example - Invitrogen - Introduction to the Company from the CEO ... USA Voicemail and Fax: (+1) 415 680 2472. All rights reserved. ...
http://www.bioportfolio.com/video/...
|
BioPortfolio - siro clinpharm
NeoPharm, Inc. Announces Second Quarter 2008 Financial Results . ... starting the first Indian Clinical Research Company, Siro Clinpharm Private Limited. ...
http://www.bioportfolio.com/search/siro_clinpharm_.html...
|
BioPortfolio - ergomart
chimica | neopharm AND doxorubicin | ergomart | Genespan Corporation | pharmacia biotech ... USA Voicemail and Fax: (+1) 415 680 2472. All rights reserved. ...
http://www.bioportfolio.com/search/ergomart.html...
|
BioPortfolio - lakeside pharmaceuticals
22 May 2008 ... Research and Development Facility, NeoPharm, Inc., 1850 Lakeside Drive, . ... Lakeside Drive, Suite A Foster City California 94404 U.S.A. . ...
http://www.bioportfolio.com/search/lakeside_pharmaceuticals....
|
Results from other life science and pharmaceutical sites:
BioPortfolio - NeoPharm
NeoPharm is a pharmaceutical Company engaged in the research and development of ... Research and Development, NeoPharm Inc., Waukegan, Illinois 60085, USA. ...
http://www.bioportfolio.com/biocorporate/7437-NeoPharm.html...
|
NeoPharm Granted Additional Time to Regain Listing Compliance on ...
NeoPharm, Inc., based in Lake Bluff, Illinois, is a publicly traded biopharmaceutical company dedicated to the research, development and
commercialization ...
http://biz.yahoo.com/bw/080904/20080904005179.html?.v=1...
|
BioSpace - NeoPharm News, Search Jobs, Events
NeoPharm Inc. 100 Corporate North, Suite 215 Bannockburn Illinois 60015 U.S.A. Phone: 847-295-8678-Ext-115 Fax: 847-295-8854 ...
http://www.biospace.com/company_profile.aspx?CompanyID=2445...
|
NeoPharm, Inc. Announces Second Quarter 2008 Financial Results ...
NeoPharm anticipates that this Phase III trial will generate substantial data by the end of calendar year 2009. The Company will evaluate the results from ...
http://biz.yahoo.com/bw/080814/20080814006027.html?.v=1...
|
NeoPharm Presents Pre-Clinical Data for LEP-ETU and LE-SN38 at ...
About NeoPharm NeoPharm, Inc., based in Lake Forest, IL, is a publicly traded biopharmaceutical company dedicated to the research, discovery and ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
NEOL: Profile for NEOPHARM INC - Yahoo! Finance
See the company profile for NEOPHARM INC (NEOL) including business summary, industry/sector information, number of employees, business summary, ...
http://biz.yahoo.com/p/N/NEOL.html...
|
NeoPharm Announces Efficacy Results For Phase 3 PRECISE Trial ...
The NEOPHARM Board of Directors and Senior Management have created a task force to evaluate Company options moving forward, including advancement of the ...
http://www.biospace.com/news_story.aspx?NewsEntityId=39560...
|
Summary of NEOPHARM INC - Yahoo! Finance
On June 12, 2008, NeoPharm, Inc. (the "Company") announced that effective June 13, 2008, the listing of the Company's common stock will be transferred from ...
http://biz.yahoo.com/e/080612/neol8-k.html...
|
hIL-13-PE38QQR NeoPharm Stefan Barth
In October 1999, NeoPharm initiated phase I trials of hIL-13-. PE38QQR for the treatment of patients with RCC [343878]. In February 2000, Dirks & Co ...
http://www.biomedcentral.com/content/pdf/cd-420797.pdf...
|
NeoPharm Granted Additional Time to Regain Listing Compliance on ...
LAKE BLUFF, Ill.--(BUSINESS WIRE)--NeoPharm, Inc. (NASDAQ: NEOL), today announced that, on September 2, 2008, the Company received a letter from the
NASDAQ ...
http://www.biospace.com/news_story.aspx?NewsEntityId=108693...
|
|
